TG Therapeutics Class Action Lawsuit TGTX | Deadline September 16, 2022

TG Therapeutics, Inc. (TGTX) is facing a class action lawsuit (TG Therapeutics Class Action Lawsuit) alleging that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) clinical trials revealed significant concerns related to the benefit-risk ratio and overall survival data of the Company’s therapeutic product candidates, Ublituximab and Umbralisib; (ii) accordingly, it was unlikely that the Company would be able to obtain approval from the U.S. Food and Drug Administration of the Umbralisib marginal zone lymphoma and follicular lymphoma New Drug Application, the Biologics License Application for Ublituximab in combination with Umbralisib, the supplemental New Drug Application for Ublituximab in combination with Umbralisib, or the Ublituximab relapsing forms of multiple sclerosis Biologics License Application in their current forms; (iii) as a result, the Company had significantly overstated Ublituximab and Umbralisib’s clinical and/or commercial prospects; and (iv) therefore, the Company’s public statements were materially false and misleading at all relevant times.

If you incurred a loss on TGTX stocks purchased between January 15, 2020 and May 31, 2022, this lawsuit is on your behalf. The lawsuit was filed in the United States District Court for the Southern District of New York, and our firm is reaching out to investors to discuss their legal rights.

If you wish to act as a representative of the shareholders harmed by this misconduct, you may ask the court to appoint you as lead plaintiff. A lead plaintiff directs the litigation and participates in important decisions, including whether to accept a settlement for the class in the action.

You only have until September 16, 2022 to apply to be lead plaintiff. The court will then evaluate the applicants and choose a lead plaintiff. You are not required to act as a lead plaintiff in order to participate in any recovery.

TG Therapeutics, Inc. Class Action Lawsuit
TG Therapeutics, Inc. Lawsuit
TGTX Class Action Lawsuit
TGTX Lawsuit
TG Therapeutics, Inc. (TGTX) Class Action Lawsuit

TG Therapeutics Class Action Lawsuit,
TG Therapeutics Class Action,
TG Therapeutics Lawsuit,
TGTX Class Action Lawsuit,
TGTX Class Action,
TGTX Lawsuit,
TGTX stock